C30 H35 Cl Ir N3 O4 S2
8TH
[(benzenesulfonyl){[4-(4-sulfamoylphenyl)pyridin-2-yl-kappaN]methyl}azanido-kappaN]chlorido[(1,2,3,4,5-eta)-1,2,3,5-tetramethyl-4-propylcyclopentadienyl]iridium
Description
Physiochemical properties
Bound structures
Interaction statistics
Ligand-specific databases
We have redesigned this page to enhance your experience. Take an on-page tour.
Synonyms
[(benzenesulfonyl){[4-(4-sulfamoylphenyl)pyridin-2-yl-kappaN...Show more
Formula
Standard InChI
InChI=1S/C18H16N3O4S2.C12H19.ClH.Ir/c19-26(22,23)17-8-6-14(7-9-17)15-10-11-20-16(12-15)13-21-27(24,25)18-4-2-1-3-5-18;1-...Show more
Standard InChI Key
MQIPAPWTTHRPKT-UHFFFAOYSA-M
SMILES
CCCC12=C3([Ir]1456(C2(=C4(C53C)C)C)(N(CC7=[N]6C=CC(=C7)c8ccc...Show more
Source OpenEye
First observed in
Overall view, and highlighted
scaffolds and fragments ![help icon]()
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
This image gallery displays several views of the ligand structure:
- Basic Structural Representation: Shows the overall structure of the ligand.
- Detailed Structural Representation: Highlights individual atoms within the ligand.
- Murcko Scaffold: Presents the scaffold of the ligand highlighted in yellow.
- Highlighted Fragments: Displays various ligand fragments, highlighted in yellow.
Displayed: 1 / 2